Author Question: Tom believes that studying while listening to music will improve test performance. To test this ... (Read 64 times)

nenivikky

  • Hero Member
  • *****
  • Posts: 516
Tom believes that studying while listening to music will improve test performance. To test this hypothesis, Tom has one group of participants listen to music while studying for a spelling test.
 
  A second group of participants study for the test in silence. Tom then compares the spelling test performance for both groups. Tom's study is best described as which type of experimental design?
   a. between-subjects
   b. within-subjects
   c. repeated measures
   d. simple factorial

Question 2

Experimental designs that expose subjects to only one treatment condition each are referred to as
 
  a. randomized designs.
  b. repeated-measures designs.
  c. within-subject designs.
  d. between-subjects designs.



leeeep

  • Sr. Member
  • ****
  • Posts: 315
Answer to Question 1

a

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

Did you know?

The modern decimal position system was the invention of the Hindus (around 800 AD), involving the placing of numerals to indicate their value (units, tens, hundreds, and so on).

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

The first oncogene was discovered in 1970 and was termed SRC (pronounced "SARK").

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library